INNOVATION FUND Technology and AI in Healthcare SHOWCASE 2019 View Innovation Fund Showcase 2019 Awardees View Photos from the Event INNOVATION FUND Technology and AI in Healthcare SHOWCASE 2019 View Innovation Fund Showcase 2019 Awardees View Photos from the Event

David Berman

Dr. David Berman is the Director of the Queen’s Cancer Research Institute (2015- present) and a Professor of Pathology and Molecular Medicine at Queen’s University. He practices genitourinary surgical pathology and runs a research laboratory focused on biomarkers that guide management decisions for patients with prostate and bladder cancer. He also chairs the Research Advisory Committee for Prostate Cancer Canada as well as the Genitourinary Correlative Science Committee for the Canadian Cancer Trials Group. Prior to moving to Queen’s in 2012, Dr. Berman’s clinical practice and laboratory were located at The Johns Hopkins Medical Institutions in Baltimore, Maryland.

Dr. Berman received his Doctor of Medicine and PhD degrees from UT Southwestern in Dallas Texas. He completed anatomic residency training and a postdoctoral fellowship in Molecular BIology and Genetics at Johns Hopkins.

Dr. Berman’s research work ranges from mechanistic, genomic, bioinformatic, and pharmacologic investigation of oncogenic signaling pathways to practical advances in cancer diagnostics.

©2020 IFPOC - The Innovation Fund Provincial Oversight Committee - created by Techna

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

Forgot your details?